FDA Import Refusal E7E-1026048-2/4/8 — Marlex Pharmaceuticals, Inc.
The FDA refused shipment E7E-1026048-2/4/8 from Marlex Pharmaceuticals, Inc. (United States) on April 6, 2012. The refused product falls under Drugs and Biologics — ASPIRIN (ANALGESIC). Cited charges: 118,75
Refusal Details
- Date
- April 6, 2012
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 60LAA05 ASPIRIN (ANALGESIC)
- Charges
- 118,75